Peripheral Arterial Disease

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Safety and Preliminary Efficacy of Adipose Derived Stem Cells and Low Frequency Ultrasound in Peripheral Arterial Disease

Condition:   Peripheral Arterial Disease
Interventions:   Procedure: Lipoaspiration;   Other: Intravenous injection of Adipose Derived Stem Cells;   Other: Intra-adventitia (proximal to the lesion) injection of Adipose Derived Stem Cells;   Other: Intra-muscular injection of Adipose Derived Stem Cells;   Other: Low Frequency Ultrasound (LoFU) Delivery
Sponsors:   Arkansas Heart Hospital;   National Institutes of Health (NIH);   SonaCare Medical
Recruiting - verified April 2016

RISCAID Study: Remote ISchemic Conditioning for Angiopathy In Diabetes

Condition:   Peripheral Arterial Disease
Interventions:   Device: AutoRIC: Remote Ischemic Conditioning;   Device: AutoRIC: Sham device treatment
Sponsors:   Steno Diabetes Center;   Aarhus University Hospital;   German Diabetes Center
Not yet recruiting - verified April 2016

Post-revascularization Rehabilitation to Improve Function in Veterans With PAD

Conditions:   Peripheral Arterial Disease;   Intermittent Claudication
Interventions:   Other: Exercise training;   Other: NMES
Sponsor:   VA Office of Research and Development
Recruiting - verified April 2016

Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

Conditions:   Diabetic Foot;   Peripheral Arterial Disease
Interventions:   Drug: PDA-002;   Drug: Placebo
Sponsor:   Celgene Corporation
Withdrawn - verified April 2016

Women's Health Initiative Strong and Healthy Study

Conditions:   Myocardial Infarction;   Stroke;   Cardiovascular Mortality;   Hip Fractures;   Falls;   Mortality;   Venous Thromboembolic Event;   Peripheral Artery Disease
Intervention:   Behavioral: Physical Activity
Sponsors:   Fred Hutchinson Cancer Research Center;   University of California, San Diego;   Stanford University;   National Heart, Lung, and Blood Institute (NHLBI)
Enrolling by invitation - verified April 2016

Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease

Conditions:   Peripheral Arterial Disease;   Diabetic Foot
Interventions:   Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Other: Placebo
Sponsor:   Celgene Corporation
Recruiting - verified April 2016

The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis

Condition:   Hypertension, Resistant to Conventional Therapy
Intervention:  
Sponsors:   Chinese Academy of Medical Sciences, Fuwai Hospital;   Huazhong University of Science and Technology;   Shanghai Jiao Tong University School of Medicine
Active, not recruiting - verified April 2016

The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses

Condition:   Venous Thrombosis
Intervention:   Device: Gore Viabahn Heparin Coated Stent
Sponsor:   Stanford University
Terminated - verified April 2016

Feasibility Study of the TGI Adipose-derived Stromal Cell (ASC)-Coated ePTFE Vascular Graft

Condition:   Lower Limb Ischemia
Interventions:   Device: ASC coated ePTFE vascular graft;   Device: Propaten graft
Sponsor:   Tissue Genesis, Inc.
Active, not recruiting - verified April 2016